Año 2019 / Volumen 111 / Número 8
Original
The main determinants of disability in IBD and its relationship to optimism

579-585

DOI: 10.17235/reed.2019.6033/2018

Juliana M. Costa, Diana Matos, Bruno Arroja, Raquel Gonçalves, João B. Soares,

Resumen
Background and aim: inflammatory bowel disease (IBD) is a potentially disabling chronic disease that negatively affects many aspects of the patients’ life. This study aimed to assess the IBD-associated disability in the outpatient setting and analyze how optimism and disability are related. Methods: a cross-sectional study was performed via the application of the Portuguese version of the IBD-Disability Index (PT-IBD-DI) and the Revised Life Orientation Test (PT-LOT-R) for the assessment of disability and optimism, respectively. Results: a total of 143 patients were analyzed, the mean age was 38 ± 13 years, 50% were females and 51% had UC. The mean PT-IBD-DI score was 22 ± 17, which was classified as follows: 0-20: no disability; 20-35: mild disability; 35-50: moderate disability; and 50-100: severe disability. There were no significant differences between Crohn’s disease (CD) and ulcerative colitis (UC) (p = 0.944). Female gender (p = 0.001), low level of education (p = 0.018), the number of days out of work (p = 0.020), rheumatologic manifestations (p = 0.005), the number of comorbidities (p = 0.002), the use psychotropic drugs (p = 0.043) and low PT-LOT-R scores (p < 0.001) were associated with higher IBD-DI scores according to the univariate analysis. According to the linear regression analysis, only female sex (p = 0.001), the number of comorbidities (p = 0.034) and low PT-LOT-R scores (p < 0.001) were associated with higher PT-IBD-DI scores. Optimism correlated inversely with PT-IBD-DI scores (ρ = -0.345, p < 0.001). Conclusion: IBD outpatients reported low levels of IBD-disability (mild disability: PT-IBD-DI score 20-35). Comorbidities and psychological factors (optimism) emerged as the main predictive factors of increased disability, reinforcing the importance of a multidisciplinary approach for these patients.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
(1) Casellas F, Lopez-Vivancos J, Vergara M et al. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis 1999;17:208-18.
(2) Peyrin-Biroulet L. What is the patient's perspective: How important are patient-reported outcomes, quality of life and disability? Dig Dis 2010;28:463-71.
(3) Peyrin-Biroulet L, Cieza A, Sandborn WJ et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012;61:241-7.
(4) Gower-Rousseau C, Sarter H, Savoye G et al. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort. Gut 2017;66:588-96.
(5) Soares JB, Pereira R, Costa JM et al. The Inflammatory Bowel Disease-Disability Index: validation of the Portuguese version according to the COSMIN checklist. Eur J Gastroenterol Hepatol 2016;28:1151-60.
(6) van der Have M, van der Aalst KS, Kaptein AA et al. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis 2014;8:93-106.
(7) Berroa de la Rosa, Mora Cuadrado Natalia, Fernandez Salazar Luis. Las preocupaciones de los pacientes españoles con enfermedad inflamatoria intestinal medidas con el cuestionario RFIPC. Rev Esp Enferm Dig 2017;109 (3):196-201.
(8) Dür M, Sadloňová M, Haider S et al. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis 2014;8:45-55.
(9) Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. Pers Soc Psychol 1994;67:1063-78.
(10) Carver CS, Scheier MF. Dispositional optimism. Trends Cogn Sci 2014;18:293-9.
(11) Laranjeira CA. Portuguese Translation and Validation of the Revised Life Orientation Test. Univ Psychol 2008;7:469-76.
(12) Peyrin-Biroulet L, Sandborn W, Sands BE et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol 2015;110:1324-38.
(13) Leong RW, Huang T, Ko Y et al. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis. J Crohns Colitis 2014;8:1237-45.
(14) van der Have M, Fidder HH, Leenders M et al. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions. Inflamm Bowel Dis 2015;21: 69-77.
(15) Williet N, Sarter H, Gower-Rousseau C et al. Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients. J Crohns Colitis 2017;11:165-74.
(16) Fernández O, Baumstarck-Barrau K, Simeoni MC, Auquier P; MusiQoL study group. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler 2011;17:1238-49.
(17) Vlassoff C. Gender differences in determinants and consequences of health and illness. J Health Popul Nutr 2007;25:47-61.
(18) Boerma T, Hosseinpoor AR, Verdes E et al. A global assessment of the gender gap in self-reported health with survey data from 59 countries. BMC Public Health 2016;16:675.
Artículos relacionados

Carta

Linfoma T hepatoesplénico y enfermedad inflamatoria intestinal

DOI: 10.17235/reed.2023.9472/2023

Carta

Apoptotic colopathy as a manifestation of Good’s syndrome

DOI: 10.17235/reed.2021.8297/2021

Original

Radon exposure and inflammatory bowel disease in a radon prone area

DOI: 10.17235/reed.2021.8239/2021

Revisión

Enfermedad inflamatoria intestinal y trasplante de órganos sólido

DOI: 10.17235/reed.2020.7361/2020

Editorial

Enfermedad inflamatoria intestinal. Nuevos modelos de atención

DOI: 10.17235/reed.2019.6495/2019

Editorial

Diet in the etiology of inflammatory bowel disease

DOI: 10.17235/reed.2018.6119/2018

Caso Clínico

Lesiones serradas en pacientes con enfermedad inflamatoria intestinal

DOI: 10.17235/reed.2019.5910/2018

Editorial

Redes sociales online y enfermedad inflamatoria intestinal

DOI: 10.17235/reed.2018.5496/2018

Carta al Editor

Hipertensión portal idiopática por tiopurinas

DOI: 10.17235/reed.2018.5256/2017

Instrucciones para citar
Costa J, Matos D, Arroja B, Gonçalves R, Soares J. The main determinants of disability in IBD and its relationship to optimism. 6033/2018


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 771 veces.
Este artículo ha sido descargado 234 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 07/11/2018

Aceptado: 29/03/2019

Prepublicado: 19/06/2019

Publicado: 31/07/2019

Tiempo de revisión del artículo: 136 días

Tiempo de prepublicación: 224 días

Tiempo de edición del artículo: 266 días


Compartir
Este artículo ha sido valorado por 1 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas